Search Results 431-440 of 24182 for In situ

1. Publications - David A. Cook, M.D., M.H.P.E. - Mayo Clinic

   Educational and Patient Care Impacts of In Situ Simulation in Healthcare: A Systematic Review. Simul Healthc. 2024 Jan 1; 19 (1S):S23-S31 View PubMed; D ...

2. I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer - Mayo Clinic

   History of carcinoma in situ of the cervix, colorectal carcinoma in situ, melanoma in situ, and basal cell and squamous cell carcinomas of the skin;; History ...

3. Robotic surgery - Doctors & Departments - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ, Lobular ...

4. Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery - Mayo Clinic

   ... in situ [LCIS] are eligible without additional resection); For patients who ... History of non-breast malignancies (except for in situ cancers treated ...

5. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

   Prior malignancy, with the exception of curatively treated squamous cell or basal carcinoma of the skin or in situ cervical cancer, unless there is a 3-year ...

6. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

   Exceptions are colonic polyps, non-melanoma skin cancer or carcinoma in-situ of the cervix. Any of the following because this study involves an agent that ...

7. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

   History of other cancer within 3 years (except non-melanoma cutaneous malignancies and cervical carcinoma in situ). Active tuberculosis or recent (< 2 week ...

8. PET Scan Imaging in Assessing Response in Patients with Esophageal Cancer Receiving Combination Chemotherapy - Mayo Clinic

   Not pregnant or nursing; Negative pregnancy test; No prior malignancy within 5 years, with the exception of basal or squamous cell skin cancers, or in situ ...

9. Publications - James W. Jakub, M.D. - Mayo Clinic

   Proteomic Analysis of Small Extracellular Vesicles From Lymphatic Affluents in Developing Premetastatic Niche in Melanoma. ... Situ of the Breast: A Challenging ...

10. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration - Mayo Clinic

    ... in situ hybridization (ISH) test 1. Part I Dose Escalation (CLOSED) Any solid tumor with * EGFR exon 20 insertion mutation * HER2 exon 20 insertion mutation